Journal article
Validity of a multi-context sitting questionnaire across demographically diverse population groups: AusDiab3
BK Clark, BM Lynch, EAH Winkler, PA Gardiner, GN Healy, DW Dunstan, N Owen
International Journal of Behavioral Nutrition and Physical Activity | Published : 2015
Abstract
Background: Sitting time questionnaires have largely been validated in small convenience samples. The validity of this multi-context sitting questionnaire against an accurate measure of sitting time is reported in a large demographically diverse sample allowing assessment of validity in varied demographic subgroups. Methods: A subgroup of participants of the third wave of the Australian Diabetes, Obesity, and Lifestyle (AusDiab3) study wore activPAL3™ monitors (7 days, 24 hours/day protocol) and reported their sitting time for work, travel, television viewing, leisure computer use and "other" purposes, on weekdays and weekend days (n = 700, age 36-89 years, 45 % men). Correlations (Pearson's..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
Also, for funding or logistical support, we are grateful to: National Health and Medical Research Council (NHMRC grants 233200 and 1007544), Australian Government Department of Health and Ageing, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, Amgen Australia, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service-Canberra, Department of Health and Community Services - Northern Territory, Department of Health and Human Services - Tasmania, Department of Health - New South Wales, Department of Health - Western Australia, Department of Health - South Australia, Department of Human Services - Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian & FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis, sanofi-synthelabo, and the Victorian Government's OIS Program.The authors were supported by: National Health and Medical Research Council of Australia (NHMRC Program Grant #APP566940 to NO; Centre of Research Excellence grant #APP1057608 to GNH, NO, and DWD with salary support to BKC; Senior Principal Research Fellowship # 1003960 to NO; Senior Research Fellowship # APP1078360 to DWD; Career Development Fellowship #1086029 to GNH; funding support to PAG from Centre of Research Excellence grant #APP1000986); Heart Foundation Postdoctoral Fellowship (# PH 12B 7054 to GNH); and, the Victorian Government's OIS Program (to NO and DWD). The funders of this study had no role in the data analysis or interpretation of the results.